Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion type Assertion NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_head.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion description "[In 2001, we initiated a clinical trial of nerve growth factor (NGF) gene therapy in AD, the first effort at gene delivery in an adult neurodegenerative disorder.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_provenance.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion evidence source_evidence_literature NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_provenance.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion SIO_000772 26302439 NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_provenance.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion wasDerivedFrom befree-2016 NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_provenance.
- NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_assertion wasGeneratedBy ECO_0000203 NP1293138.RAAxetzh_jZd3dKO9t-OfeqN3ahBYy4_cYWRUVyd_e-ec130_provenance.